Companies · MBX · Pharmaceutical Preparations

MBX Biosciences, Inc. (MBX)

MBX Biosciences, Inc. (MBX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Aug 27, 2026Phase 3 initiated

MBX Biosciences starts canvuparatide Phase 3 on schedule, with efficacy still unproven

Quarterly loss missed consensus; pipeline milestones stayed on schedule

Related companies in Pharmaceutical Preparations

ONC ELAN CMPS UTHR PRGO ETON QTTB LLY NAMS RAPP SMMT RPRX

Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact